ATE31023T1 - Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin. - Google Patents

Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.

Info

Publication number
ATE31023T1
ATE31023T1 AT84104360T AT84104360T ATE31023T1 AT E31023 T1 ATE31023 T1 AT E31023T1 AT 84104360 T AT84104360 T AT 84104360T AT 84104360 T AT84104360 T AT 84104360T AT E31023 T1 ATE31023 T1 AT E31023T1
Authority
AT
Austria
Prior art keywords
fibrinonectin
pharmaceutical preparation
preparation containing
containing purified
fibronectin
Prior art date
Application number
AT84104360T
Other languages
English (en)
Inventor
Ricardo H Landaburu
Robert H Yue
David L Farb
Bernard N Violand
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Application granted granted Critical
Publication of ATE31023T1 publication Critical patent/ATE31023T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT84104360T 1983-04-28 1984-04-17 Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin. ATE31023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48962483A 1983-04-28 1983-04-28
EP84104360A EP0124018B1 (de) 1983-04-28 1984-04-17 Pharmazeutische Zubereitung mit Gehalt an gereinigtem Fibrinonectin

Publications (1)

Publication Number Publication Date
ATE31023T1 true ATE31023T1 (de) 1987-12-15

Family

ID=23944603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84104360T ATE31023T1 (de) 1983-04-28 1984-04-17 Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.

Country Status (7)

Country Link
EP (1) EP0124018B1 (de)
JP (1) JPS59206312A (de)
AT (1) ATE31023T1 (de)
AU (1) AU561590B2 (de)
CA (1) CA1214102A (de)
DE (1) DE3467706D1 (de)
ZA (1) ZA842984B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
AT385658B (de) * 1985-03-28 1988-05-10 Serotherapeutisches Inst Wien Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
JPH03504499A (ja) * 1988-05-27 1991-10-03 セントカー・インコーポレーテツド 抗体試薬のための配合物
EP0417193B1 (de) * 1988-05-27 1993-08-04 Centocor, Inc. Gefriergetrocknete formulierung für antikörperprodukte
NZ232763A (en) * 1989-03-06 1991-09-25 Lilly Co Eli Parenteral formulation comprising daptomycin with a buffer to maintain ph between 6.0 and 8.0
CA2024046A1 (en) * 1989-09-28 1991-03-29 Alberto Ferro Stabilized leukocyte-interferons
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
JP7541993B2 (ja) 2019-03-14 2024-08-29 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥用ローディングトレイ組立体、凍結乾燥システム及び凍結乾燥方法
CN117860608A (zh) * 2023-12-28 2024-04-12 深圳柏垠生物科技有限公司 一种速溶型纤连蛋白冻干粉及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
JPS5767520A (en) * 1980-10-13 1982-04-24 Katsuyuki Haranaka Preparation of antitumor agent
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法

Also Published As

Publication number Publication date
JPS59206312A (ja) 1984-11-22
CA1214102A (en) 1986-11-18
AU561590B2 (en) 1987-05-14
DE3467706D1 (en) 1988-01-07
EP0124018A1 (de) 1984-11-07
EP0124018B1 (de) 1987-11-25
AU2740284A (en) 1984-11-01
ZA842984B (en) 1984-11-28

Similar Documents

Publication Publication Date Title
DE3768052D1 (de) Optisch aktive adsorbentien.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE3486255D1 (de) Pharmazeutische Zusammensetzungen.
MX9203480A (es) Formulaciones medicinales en aereosol.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
FI895821A0 (fi) Farmaceutiskt aktiva cns foereningar.
DE3766533D1 (de) Kinderlaufstuhl.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
DE68927394D1 (de) Paritätsprüfgerät
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
ATE31023T1 (de) Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
DE58903011D1 (de) Gesichtsmaske.
NO870533D0 (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
DK394084A (da) Fysiologisk aktive praeparater
DE3881198D1 (de) Antiviraler wirkstoff.
DE3483900D1 (de) Pharmazeutische zusammensetzungen.
DE68907609D1 (de) Arzneimittelzusammensetzung.
FI883254A0 (fi) Cytostatiskt aktiva antracyklinderivat.
DE68921230D1 (de) Optisch-aktive Pyridylethanol-Derivate.
DE3880600D1 (de) Oberflaechenaktives polymer.
FI911325A0 (fi) Osmotiska absorbenter.
DE68909896D1 (de) Bodenbearbeitungsmaschine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee